The Company only enters into basic financial instrument transactions that result in the recognition of financial assets
and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related
parties investments in non-puttable ordinary shares.
Debt instruments (other than those wholly repayable or receivable within one year), including loans and other
accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at
amortised cost using the effective interest method. Debt instruments that are payable or receivable within on year,
typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash
or other consideration expected to be paid or received. However, if the the arrangements of a short-term instrument
consittutes a financial transaction, like the payment of a trade debt deferred beyond normal business terms or
financed at a rate of interest that is not a market rate or in the case of an out-right short-term loan not at market rate,
the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market
rate of interest for a similar debt instrument and subsequently at amortised cost.
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for
objective evidence of impairment. If objective evidence of impairment is found , an impairment loss is recognised in
the Statement of comprehensive income.